To Evaluate the Pharmacokinetics and Safety of AD-208

NCT04214808 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenetic Alopecia

Interventions

DRUG: AD-208
DRUG: Avodart Soft Capsule 0.5mg

Sponsor

Addpharma Inc.